Societal Cdmo San Diego, LLC
Doing business as Irisys Inc. Part of Irisys, Inc.
- UEI
- YRPTVKHDL7Z5
- CAGE
- 7B0Z1
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Irisys, Inc.
Parent
FHHKP5KCJ5R7
- Societal Cdmo San Diego, LLC YRPTVKHDL7Z5
-
Irisys, Inc.
Parent
FHHKP5KCJ5R7
- SAM.gov registration date
- Website
- tpptech.com
- Founded
- 2015
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Capital Goods
- Industrial Conglomerates
- Industrials & Manufacturing
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| For payment only PO. Ratification of unauthorized commitment number 20045; irisys; $13,375.00;november 6, 2018. | National Cancer Institute | $13,375 | |
| Metarrestin cgmp manufacturing and stability testing services | National Cancer Institute | $711,750 | |
| Societal is a small business concern for dosage form development, manufacture, and stability studies of NCGC72 | National Institute on Drug Abuse | $748,487 | |
| Metarrestin storage and stability testing services | National Cancer Institute | $78,600 | |
| Placebo & active imiquimod | Veterans Integrated Service Network 4 | $0 |
About Societal Cdmo San Diego, LLC
Societal Cdmo San Diego, LLC, doing business as Irisys Inc., is a contract development and manufacturing organization (CDMO) specializing in pharmaceutical product development, manufacturing, and testing services for federal government agencies. Registered in SAM.gov since January 2015, the company is a self-certified small disadvantaged business structured as a for-profit limited liability company and a subsidiary of Recro Pharma, Inc. The organization provides critical pharmaceutical services across various therapeutic areas, with a primary focus on developing and manufacturing investigational drugs for clinical trials and research purposes.
The company has consistently provided pharmaceutical development services to multiple federal agencies, particularly within the National Institutes of Health (NIH) ecosystem. Its contract awards primarily involve developing and manufacturing specialized drug products, including capsules, injectable solutions, and nasal sprays for clinical research. Societal Cdmo has worked extensively with agencies such as the National Cancer Institute, National Center for Advancing Translational Sciences, National Institute on Drug Abuse, and the Department of Veterans Affairs. The majority of its contracts are firm fixed-price delivery orders under multiple award indefinite delivery/indefinite quantity (IDIQ) contract vehicles, focusing on drug product development across oncology, neurology, addiction, and rare disease research. Most contracts are not set aside for specific business categories, demonstrating the company's competitive capabilities in pharmaceutical manufacturing and development.
Societal Cdmo holds two primary federal contract Indefinite Delivery Vehicles (IDVs), both with civilian agencies. The first is a single-award IDV with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4, valued at $2,010,645 and running through April 2026, focused on pharmaceutical manufacturing of imiquimod products. The second IDV, also a single-award contract, was established with the same VA network in December 2021, valued at $1,573,950, specifically for imiquimod research study support. These IDVs enable the company to provide specialized pharmaceutical manufacturing services, including developing active pharmaceutical ingredients, creating placebo formulations, and supporting clinical research through precise, FDA-compliant manufacturing processes.
Contract vehicles
Quick answers
What is Societal Cdmo San Diego, LLC's UEI?
Societal Cdmo San Diego, LLC's Unique Entity ID (UEI) in SAM.gov is YRPTVKHDL7Z5.
What is Societal Cdmo San Diego, LLC's CAGE code?
Societal Cdmo San Diego, LLC's CAGE code is 7B0Z1.
What is Societal Cdmo San Diego, LLC's primary NAICS code?
Societal Cdmo San Diego, LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Is Societal Cdmo San Diego, LLC registered in SAM.gov?
Societal Cdmo San Diego, LLC's SAM.gov registration expired on April 18, 2026.
Who is Societal Cdmo San Diego, LLC's parent company?
Societal Cdmo San Diego, LLC is part of Irisys, Inc.
Which contract vehicles does Societal Cdmo San Diego, LLC hold?
Societal Cdmo San Diego, LLC holds a place on 2 federal contract vehicles, including Drug Formulation and Manufacturing Contracts 2019 and NCATS Drug Product Development Studies 2017-2022.
What is Societal Cdmo San Diego, LLC's most recent federal award?
Societal Cdmo San Diego, LLC's most recent federal contract award is For payment only PO. Ratification of unauthorized commitment number 20045; irisys; $13,375.00;november 6, 2018 (75N91024P00518), from National Cancer Institute, on June 26, 2024.
On GovTribe
See Societal Cdmo San Diego, LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors